PD-L1 overexpression has been observed in various types of solid tumors, including melanoma, lung cancer, breast cancer, colorectal cancer, bladder cancer, gastric cancer, hepatocellular carcinoma, renal cell carcinoma, papillary thyroid cancer, and head and neck cancer [13–23]. Here, CD274 is linked to breast cancer.